1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Cures Within Reach – Clinical Trials to Validate AI-Driven Drug Repurposing is sponsored by Cures Within Reach. This grant supports investigator-initiated, proof-of-concept, Phase I or Phase IIA clinical trials to validate artificial intelligence (AI)-driven repurposing opportunities in any unsolved disease.
The therapies supported by AI models must already be approved, and eligible trials must include AI-generated data as part of the preclinical support for the trial. This could be highly relevant for identifying existing drugs that AI suggests could be effective in colorectal cancer.
Get alerted about grants like this
Save a search for “Cures Within Reach” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Investigator-initiated projects, likely targeting academic institutions and research organizations. Requires an institutional match. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000 (plus 10% institutional match). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Cures Within Reach – Clinical Trials to Validate AI-Driven Drug Repurposing are due June 26, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Cures Within Reach – Clinical Trials to Validate AI-Driven Drug Repurposing is funded by Cures Within Reach. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Department of Education's May 19 final rule activates Workforce Pell on July 1, 2026, opening federal aid to short-term training programs as brief as 8 weeks. Governors and state workforce boards — not accreditors — pick the eligible industries, and only programs that pass earnings-vs-cost gates make the list.
Read articleA new executive order, a DOJ National Fraud Enforcement Division, and a multi-agency task force are creating the most powerful federal grant enforcement apparatus in decades. What every recipient needs to understand.
Read articleImpoundment, pocket rescissions, termination for convenience, forward funding mandates, and agency staffing collapse — the five mechanisms that can kill a federal grant after Congress appropriates the money. A practical guide to the new funding uncertainty.
Read article